share_log

李氏大藥廠:自願性公佈 - 香港首名患者於第I期肝癌臨床試驗中接受AU409 (由兆科廣州製造之新藥產品) 治療

LEE'S PHARM: Voluntary Announcement - The First Patient in Hong Kong Receives AU409, a Novel Drug Product Manufactured by Zhaoke Guangzhou, in a Phase I Liver Cancer Clinical Trial

Hong Kong Stock Exchange ·  Aug 1 09:35
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more